Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide association study of idiopathic pulmonary fibrosis susceptibility using clinically curated European ancestry datasets.

The European respiratory journal·2026
Same author

A journey of 1000 miles begins with a single step-proteomics, hyperinflation, and chronic obstructive pulmonary disease.

Annals of the American Thoracic Society·2026
Same author

Author Correction: Hypoxia induces histone clipping and H3K4me3 loss in neutrophil progenitors resulting in long-term impairment of neutrophil immunity.

Nature immunology·2025
Same author

Hypoxia induces histone clipping and H3K4me3 loss in neutrophil progenitors resulting in long-term impairment of neutrophil immunity.

Nature immunology·2025
Same author

Sex-specific genetic effects on susceptibility to idiopathic pulmonary fibrosis.

ERJ open research·2025
Same author

Do You Believe in Magic? Computed Tomography, Artificial Intelligence, and Chronic Obstructive Pulmonary Disease.

American journal of respiratory and critical care medicine·2025

Related Experiment Videos

Pathological networking: a new approach to understanding COPD.

Ian Sabroe1, Lisa C Parker, Peter M A Calverley

  • 1Academic Unit of Respiratory Medicine, L Floor, Royal Hallamshire Hospital, Sheffield S10 2JF, UK. i.sabroe@sheffield.ac.uk

Thorax
|August 10, 2007
PubMed
Summary

Developing new treatments for chronic obstructive pulmonary disease (COPD) is challenging due to irreversible tissue damage. Understanding COPD as a complex immune network may refine strategies for effective therapeutic development.

Related Experiment Videos

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Pathology

Background:

  • Chronic obstructive pulmonary disease (COPD) presents as a chronic condition with irreversible tissue damage.
  • The disease progression is difficult to influence, and reversal is nearly impossible.
  • Identifying key pathological targets for substantial clinical benefit remains a significant challenge.

Purpose of the Study:

  • To examine the nature of COPD.
  • To explore the pathological network of COPD using conceptual information and simple tissue models of inflammation.
  • To suggest refinements to treatment development strategies based on a network-disease concept.

Main Methods:

  • Review of existing literature and conceptual information.
  • Utilizing simple tissue models of inflammation.
  • Conceptualizing COPD as a disease network.

Main Results:

  • COPD involves a complex pathological network.
  • The disease exhibits features of contiguous immunity, with continuous dialogue between innate and adaptive immunity.
  • Existing treatment strategies may need refinement.

Conclusions:

  • Viewing COPD as a network of contiguous immunity offers new insights.
  • Refined strategies targeting this network could lead to more effective treatments for COPD.
  • Further research into the immune network of COPD is warranted.